Takayasu arteritis (TA) is a chronic, idiopathic, inflammatorydisease that primarily affects large vessels [1]. The management ofthis disorder is largely unresolved, since a large number of patientsfail to reach stable remission on conventional treatment. anti-TNF treatmentmay prove useful both for disease control and to avoid the risk oflong-term toxicity of corticosteroids and classical immunosuppressivedrugs in Takayasu arteritis.
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? / DELLA ROSSA, A; Tavoni, A; Merlini, G; Baldini, C; Sebastiani, Marco; Lombardi, M; Neglia, D; Bombardieri, S.. - In: RHEUMATOLOGY. - ISSN 1462-0324. - STAMPA. - 44:8(2005), pp. 1074-1075. [10.1093/rheumatology/keh661]
Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?
SEBASTIANI, Marco;
2005
Abstract
Takayasu arteritis (TA) is a chronic, idiopathic, inflammatorydisease that primarily affects large vessels [1]. The management ofthis disorder is largely unresolved, since a large number of patientsfail to reach stable remission on conventional treatment. anti-TNF treatmentmay prove useful both for disease control and to avoid the risk oflong-term toxicity of corticosteroids and classical immunosuppressivedrugs in Takayasu arteritis.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Two Takayasu arteritis patients successfully treated with infliximab.pdf
Solo gestori archivio
Tipologia:
Versione pubblicata dall'editore
Dimensione
73.21 kB
Formato
Adobe PDF
|
73.21 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
